YAP1 and neoplasm: In the past decade, increasing evidence has emerged to support the contribution of the dysfunctional Hippo pathway, especially core Hippo signaling effectors yes-associated protein 1 (YAP1) and WW domain-containing transcription regulator 1 (TAZ), in tumor initiation, progression, and recurrence.